ncRNA name
CircFN1
Specific or universal ncRNAs
Specific ncRNAs
Class
Circular RNA
Biomarker
None
Biomarker application
Upstream regulatory factors
Not available
Downstream target
miR-1205/E2F1
Cancer name
Hepatocellular Carcinoma
Cancer site
qRT-PCR,Western blot,Dual-luciferase assay
Treatment type
Chemotherapy
Drug
Sorafenib
Impact of wild-type ncRNA on chemotherapy resistance
Up
Impact of knockdown of ncRNA on chemotherapy resistance
Impact of overexpression of ncRNA on chemotherapy resistance
ncRNA differential expression in
cancer
patients vs. healthy people
Up
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
PMID
Description
In summary, our study demonstrated that circFN1 contributes to sorafenib resistance by regulating the miR-1205/E2F1 signaling pathway
Tissue resource
paired hepatocellular carcinoma tissues
hepatocellular carcinoma cell lines HepG2
hepatocellular carcinoma cell lines Huh-7
normal human liver cell lines LO2
Experiment
None
Institute
Shanghai Eastern Hepatobiliary Surgery Hospital
the Chinese Academy of Sciences Cell Bank Type Culture Collection
Country
China
Continent
Asia